Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag PTC Therapeutics secures $1 billion deal with Novartis for Huntington's disease treatment.

flag PTC Therapeutics has signed a major deal with Novartis for its Huntington's disease treatment PTC518, securing a $1 billion upfront payment and up to $1.9 billion in future milestones. flag Novartis will take over global development and commercialization post a key study, while sharing U.S. profits with PTC. flag PTC’s stock surged over 15% on the news, reflecting the significant financial and potential therapeutic impact of the collaboration.

16 Articles